These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
208 related items for PubMed ID: 17507514
1. PCR-restriction fragment length polymorphism analysis of Campylobacter jejuni genes involved in lipooligosaccharide biosynthesis identifies putative molecular markers for Guillain-Barré syndrome. Godschalk PC, van Belkum A, van den Braak N, van Netten D, Ang CW, Jacobs BC, Gilbert M, Endtz HP. J Clin Microbiol; 2007 Jul; 45(7):2316-20. PubMed ID: 17507514 [Abstract] [Full Text] [Related]
2. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome. Koga M, Takahashi M, Masuda M, Hirata K, Yuki N. Neurology; 2005 Nov 08; 65(9):1376-81. PubMed ID: 16162859 [Abstract] [Full Text] [Related]
3. Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy. Shu XM, Cai FC, Zhang XP. Muscle Nerve; 2006 Feb 08; 33(2):225-31. PubMed ID: 16270308 [Abstract] [Full Text] [Related]
4. Antibodies induced by ganglioside-mimicking Campylobacter jejuni lipooligosaccharides recognise epitopes at the nodes of Ranvier. Moran AP, Annuk H, Prendergast MM. J Neuroimmunol; 2005 Aug 08; 165(1-2):179-85. PubMed ID: 15993494 [Abstract] [Full Text] [Related]
5. A Campylobacter jejuni gene associated with immune-mediated neuropathy. van Belkum A, van den Braak N, Godschalk P, Ang W, Jacobs B, Gilbert M, Wakarchuk W, Verbrugh H, Endtz H. Nat Med; 2001 Jul 08; 7(7):752-3. PubMed ID: 11433317 [No Abstract] [Full Text] [Related]
6. Recognition characteristics of monoclonal antibodies that are cross-reactive with gangliosides and lipooligosaccharide from Campylobacter jejuni strains associated with Guillain-Barré and Fisher syndromes. Houliston RS, Yuki N, Hirama T, Khieu NH, Brisson JR, Gilbert M, Jarrell HC. Biochemistry; 2007 Jan 09; 46(1):36-44. PubMed ID: 17198373 [Abstract] [Full Text] [Related]
13. Campylobacter jejuni cst-II polymorphisms and association with development of Guillain-Barré syndrome. Hye JB, Nachamkin I. Neurology; 2007 May 08; 68(19):1633-4. PubMed ID: 17485654 [No Abstract] [Full Text] [Related]
14. The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome. Godschalk PC, Heikema AP, Gilbert M, Komagamine T, Ang CW, Glerum J, Brochu D, Li J, Yuki N, Jacobs BC, van Belkum A, Endtz HP. J Clin Invest; 2004 Dec 08; 114(11):1659-65. PubMed ID: 15578098 [Abstract] [Full Text] [Related]
16. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies. Prendergast MM, Moran AP. J Endotoxin Res; 2000 Dec 08; 6(5):341-59. PubMed ID: 11521055 [Abstract] [Full Text] [Related]
19. A way out of the maze: Campylobacter jejuni gene polymorphisms define Guillain-Barré syndrome. Wokke JH, van den Berg LH. Neurology; 2005 Nov 08; 65(9):1350-1. PubMed ID: 16275819 [No Abstract] [Full Text] [Related]
20. TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation. Kuijf ML, Samsom JN, van Rijs W, Bax M, Huizinga R, Heikema AP, van Doorn PA, van Belkum A, van Kooyk Y, Burgers PC, Luider TM, Endtz HP, Nieuwenhuis EE, Jacobs BC. J Immunol; 2010 Jul 01; 185(1):748-55. PubMed ID: 20525894 [Abstract] [Full Text] [Related] Page: [Next] [New Search]